Diastolic heart failure;Diastolisch hartfalen

Nederlands Tijdschrift voor Geneeskunde

Volumn 147, Issue 50, 2003, Pages 2467-2470

  Smulders, Y M ^a   Stehouwer, C D A ^a   Bronzwaer, I G F ^a   Kamp, O ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

DIASTOLE; DIASTOLIC HEART FAILURE; DRUG CONTRAINDICATION; DRUG INDICATION; ECHOCARDIOGRAPHY; HEART EJECTION FRACTION; HEART FAILURE; HUMAN; HYPERTENSION; MORTALITY; OBESITY; PREVALENCE; PROGNOSIS; REVIEW; SYSTOLE; SYSTOLIC HEART FAILURE;

ADRENERGIC BETA-ANTAGONISTS; AGE FACTORS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; DIASTOLE; DIGOXIN; ECHOCARDIOGRAPHY; HEART FAILURE, CONGESTIVE; HUMANS; HYPERTENSION; OBESITY; PROGNOSIS;

EID: 0346258104     PISSN: 00282162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (30)

1. Mosterd A, Hoes AW, Grobbee DE. Epidemiology of heart failure: contours of an impending epidemic? Neth J Med 1998;53:235-44.
2. Muntinga HJ, Baars HF, Niemeyer MG, Berg F van de, Bernink PJLM, Blanksma PK. Diastolische dysfunctie van de linker ventrikel als oorzaak van hartfalen: een klinisch probleem. Ned Tijdschr Geneeskd 1995;139:2023-8.
3. Yu CM, Lin H, Yang H, Kong SL, Zhang Q, Lee SW. Progression of systolic abnormalities in patients with 'isolated' diastolic heart failure and diastolic dysfunction. Circulation 2002;105:1195-201.
4. McDermott MM, Feinglass J, Sy J, Gheorghiade M. Hospitalized congestive heart failure patients with preserved versus abnormal left ventricular systolic function: clinical characteristics and drug therapy. Am J Med 1995;99:629-35.
5. Thomas JT, Kelly RF, Thomas SJ, Stamos TD, Albasha K, Parrillo JE, et al. Utility of history, physical examination, electrocardiogram, and chest radiograph for differentiating normal from decreased systolic function in patients with heart failure. Am J Med 2002;112:437-45.
6. Gandhi SK, Powers JC, Nomeir AM, Fowle K, Kitzman DW, Rankin KM, et al. The pathogenesis of acute pulmonary edema associated with hypertension. N Engl J Med 2001;344:17-22.
7. Kitzman DW, Little WC, Brubaker PH, Anderson RT, Hundley WG, Marburger CT, et al. Pathophysiological characterization of isolated diastolic heart failure in comparison to systolic heart failure. JAMA 2002;288:2144-50.
8. Kraaij DJW van, Pol PEJ van, Ruiters AW, Swart JBRM de, Lips DJ, Lencer N, et al. Diagnosing diastolic heart failure. Eur J Heart Fail 2002;4:419-30.
9. European Study Group on Diastolic Heart Failure. How to diagnose diastolic heart failure. Eur Heart J 1998;19:990-1003.
10. Zile MR, Brutsaert DL. New concepts in diastolic dysfunction and diastolic heart failure. Part I: diagnosis, prognosis, and measurement of diastolic function. Circulation 2002;105:1387-93.
11. Vasan RS, Levy D. Defining diastolic heart failure: a call for standardized diagnostic criteria. Circulation 2000;101:2118-21.
12. Fisher M, Baessler A, Hense HW, Hengstenberg C, Muscholl M, Holmer S, et al. Prevalence of left ventricular diastolic dysfunction in the community. Results from a Doppler echocardiographic-based survey of a population sample. Eur Heart J 2003;24:320-8.
13. Philbin EF, Rocco jr TA, Lindenmuth NW, Ulrich K, Jenkins PL. Systolic versus diastolic heart failure in community practice: clinical features, outcomes, and the use of angiotensin-converting enzyme inhibitors. Am J Med 2000;109:605-13.
14. Kenchaiah S, Evans JC, Levy D, Wilson PWF, Benjamin EJ, Larson MG, et al. Obesity and the risk of heart failure. N Engl J Med 2002;347:305-13.
15. Senni M, Redfield MM. Heart failure with preserved systolic function. A different natural history? J Am Coll Cardiol 2001;38 1277-82.
16. Gottdiener JS, McClelland RL, Marshall R, Shemanski L, Furberg CD, Kitzman DW, et al. Outcome of congestive heart failure in elderly persons: influence of left yentricular systolic function. The Cardiovascular Health Study. Ann Intem Med 2002;137:631-9.
17. Carson P, Johnson G, Fletcher R, Cohn J. Mild systolic dysfunction in heart failure (left ventricular ejection fraction > 35%): baseline characteristics, prognosis and response to therapy in the vasodilator in heart failure trials (V-HeFT). J Am Coll Cardiol 1996;27:642-9.
18. Eriksson SV, Kjekshus J, Offstad J, Swedberg K. Patient characteristics in cases with chronic severe heart failure with different degrees of left ventricular dysfunction. Cardiology 1994;85:137-44.
19. Fujii M, Wada A, Tsutamoto T, Ohnishi M, Isono T, Kinoshita M. Bradykinin improves left ventricular diastolic function under long-term angiotensin-converting enzyme inhibition in heart failure. Hypertension 2002;39:952-7.
20. Grandi AM, Imperiale D, Santillo R, Barlocco E, Bertolini A, Guasti L, et al. Aldosterone antagonist improves diastolic function in essential hypertension. Hypertension 2002;40:647-52.
21. Aronow WS, Ahn C, Kronzon I. Effect of propranolol versus no propranolol on total mortality plus nonfatal myocardial infarction in older patients with prior myocardial infarction, congestive heart failure, and left ventricular ejection fraction > or = 40% treated with diuretics plus angiotensin-converting enzyme inhibitors. Am J Cardiol 1997;80:207-9.
22. The Digitalis Investigation Group. The effect of digoxin on mortality and morbidity in patients with heart failure. N Engl J Med 1997;336:525-33.
23. Hassapoyannes CA, Bergh ME, Movahed MR, Easterling BM, Omoigui NA. Diastolic effects of chronic digitalization in systolic heart failure. Am Heart J 1998;136:688-95.
24. Hung MJ, Cherng WJ, Kuo LT, Wang CH. Effect of verapamil in elderly patients with left ventricular diastolic dysfunction as a cause of congestive heart failure. Int J Clin Pract 2002;56:57-62.
25. Setaro JF, Zaret BL, Schulman DS, Black HR, Soufer R. Usefulness of verapamil for congestive heart failure associated with abnormal left ventricular diastolic filling and normal left ventricular systolic performance. Am J Cardiol 1990;66:981-6.
26. Swedberg K, Pfeffer M, Granger C, Held P, McMurray J, Ohlin G, et al. Candesartan in heart failure - assessment of reduction in mortality and morbidity (CHARM): rationale and design. Charm-Programme Investigators. J Card Fail 1999;5:276-82.
27. Cleland JG, Tendera M, Adamus J, Freemantle N, Gray CS, Lye M, et al. Perindopril for elderly people with chronic heart failure: the PEP-CHF study. The PEP investigators. Eur J Heart Fail 1999;1:211-7.
28. Shibata MC, Flather MD, Böhm M, Borbola J, Cohen-Solal A, Dumitrascu D, et al. Study of the effects of nebivolol intervention on outcomes and rehospitalisation in seniors with heart failure (SENIORS). Rationale and design. Int J Cardiol 2002;86:77-85.
29. Sanderson JE. The HONGKONG study [letter]. Eur J Heart Fail 2000;2:117.
30. Yusuf S, Pfeffer MA, Swedberg K, Granger CB, Held P, McMurray JJV, et al. Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial. Lancet 2003;362:777-81.